Last reviewed · How we verify
MT200605
At a glance
| Generic name | MT200605 |
|---|---|
| Sponsor | Shaanxi Micot Pharmaceutical Technology Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke (PHASE2)
- A SAD/MAD Study to Evaluate the Safety, Tolerability, PK of MT200605 in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MT200605 CI brief — competitive landscape report
- MT200605 updates RSS · CI watch RSS
- Shaanxi Micot Pharmaceutical Technology Co., Ltd. portfolio CI